Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aurion Biotech
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have a diagnosis of corneal edema secondary to corneal endothelial dysfunction, requiring surgery (full- or partial-thickness endothelial keratoplasty)
BCVA between 65 Early Treatment of Diabetic Retinopathy Study (ETDRS) letters (i.e., 0.4 LogMAR or approximate 20/50 Snellen equivalent) and 5 ETDRS letters (i.e., 1.6 LogMAR or approximate 20/800 Snellen equivalent)
You may not be if
Have pre-operative corneal epithelial, sub-epithelial or stromal scarring or other opacity that is paracentral/central and visually significant, but not suspected to be secondary to corneal endothelial disease with the potential to improve from treatment in the study eye
Have history or presence of an ocular disease other than corneal endothelial dysfunction that could affect vision or safety assessments
Clareo Health | A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
